On August 4, 2020, Canada’s Minister of Health, Patty Hajdu, announced that four terminally ill cancer patients are now legally able to possess and consume psilocybin mushrooms for end-of-life care. These four patients mark the first publicly-known individuals to receive a legal exemption from the Canadian Drugs and Substances Act to access psychedelic therapy, and
Medicinal mushrooms, otherwise known as “magic mushrooms” is the term that is used to describe mushrooms that contain natural, active ingredients (hallucinogens), such as Psilocybin and Psilocin. In Canada, Psilocybin (chemical name: 3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and Psilocin (chemical name: 3–[2–(dimethylamino)ethyl]–4–hydroxyindole) are controlled under Schedule III of the Controlled Drugs and Substances Act (CDSA). This means that activities
Subscribe To Our Newsletter
Get Latest Industry News and Updates
